In lab tests, the combination of oritavancin and ampicillin showed further synergy with the human antimicrobial peptide LL‑37.
In plain wordsIn lab tests, the antibiotic pair oritavancin and ampicillin worked even better together with LL‑37.
- Peptide
- LL-37
- Outcome
- Not applicableSynergy of oritavancin plus ampicillin with LL-37
- Study
Enterococcus faeciumn: not reported in source
Vancomycin-resistant E. faecium isolate- Outcome group
- Infection and antimicrobial activity · Infection
Source sentences
Further synergies of oritavancin and ampicillin with rifampin or the endogenous human antimicrobial peptide cathelicidin LL-37 were demonstrated.
1 context sentence(design, population, supporting numbers)
Weekly oritavancin plus ampicillin continuous infusion combination therapy was used to successfully treat a deep spine vancomycin-resistant Enterococcus faecium infection associated with hardware.
In this study, LL-37 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking LL-37.